Vera Therapeutics (VERA) Shares Outstanding (2020 - 2026)

Vera Therapeutics (VERA) has 7 years of Shares Outstanding data on file, last reported at $71.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 12.48% year-over-year to $71.7 million; the trailing twelve-month figure through Mar 2026 stood at $71.7 million (up 12.48% YoY), and the FY2025 full-year result was $71.3 million, up 12.13% from the prior year.
• Shares Outstanding for Q1 2026 stood at $71.7 million, up from $71.3 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $71.7 million in Q1 2026 and bottomed at $309238.0 in Q1 2022.
• The 5-year median for Shares Outstanding is $54.5 million (2024), against an average of $48.4 million.
• The widest annual swing landed in 2022, when Shares Outstanding tumbled 34.06%; it then surged 14212.96% in 2023.
• A 5-year view of Shares Outstanding shows it stood at $27.8 million in 2022, then soared by 59.89% to $44.5 million in 2023, then surged by 42.98% to $63.6 million in 2024, then increased by 12.13% to $71.3 million in 2025, then climbed by 0.65% to $71.7 million in 2026.
• The last three Shares Outstanding figures came in at $71.7 million (Q1 2026), $71.3 million (Q4 2025), and $63.9 million (Q3 2025), per Business Quant data.

Peer Comparison